Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study

V. A. Papadimitrakopoulou; Y. L. Wu; J. Y. Han; M. J. Ahn; S. S. Ramalingam; T. John; I. Okamoto; J. C.H. Yang; K. C. Bulusu; G. Laus; B. Collins; J. C. Barrett; J. Chmielecki; T. S.K. Mok

doi:10.1093/annonc/mdy424.064

Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study

V. A. Papadimitrakopoulou, Y. L. Wu, J. Y. Han, M. J. Ahn, S. S. Ramalingam, T. John, I. Okamoto, J. C.H. Yang, K. C. Bulusu, G. Laus, B. Collins, J. C. Barrett, J. Chmielecki, T. S.K. Mok

Respiratory Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	viii741
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy424.064
Publication status	Published - Oct 1 2018

All Science Journal Classification (ASJC) codes

Hematology
Oncology

Access to Document

10.1093/annonc/mdy424.064

Cite this

Papadimitrakopoulou, V. A., Wu, Y. L., Han, J. Y., Ahn, M. J., Ramalingam, S. S., John, T., Okamoto, I., Yang, J. C. H., Bulusu, K. C., Laus, G., Collins, B., Barrett, J. C., Chmielecki, J., & Mok, T. S. K. (2018). Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii741. https://doi.org/10.1093/annonc/mdy424.064

Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study. / Papadimitrakopoulou, V. A.; Wu, Y. L.; Han, J. Y.; Ahn, M. J.; Ramalingam, S. S.; John, T.; Okamoto, I.; Yang, J. C.H.; Bulusu, K. C.; Laus, G.; Collins, B.; Barrett, J. C.; Chmielecki, J.; Mok, T. S.K.

In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii741.

Research output: Contribution to journal › Article › peer-review

Papadimitrakopoulou, VA, Wu, YL, Han, JY, Ahn, MJ, Ramalingam, SS, John, T, Okamoto, I, Yang, JCH, Bulusu, KC, Laus, G, Collins, B, Barrett, JC, Chmielecki, J & Mok, TSK 2018, 'Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii741. https://doi.org/10.1093/annonc/mdy424.064

Papadimitrakopoulou, V. A. ; Wu, Y. L. ; Han, J. Y. ; Ahn, M. J. ; Ramalingam, S. S. ; John, T. ; Okamoto, I. ; Yang, J. C.H. ; Bulusu, K. C. ; Laus, G. ; Collins, B. ; Barrett, J. C. ; Chmielecki, J. ; Mok, T. S.K. / Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2018 ; Vol. 29. pp. viii741.

@article{6d3167172f144124ae2d71d526a033ba,

title = "Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study",

author = "Papadimitrakopoulou, {V. A.} and Wu, {Y. L.} and Han, {J. Y.} and Ahn, {M. J.} and Ramalingam, {S. S.} and T. John and I. Okamoto and Yang, {J. C.H.} and Bulusu, {K. C.} and G. Laus and B. Collins and Barrett, {J. C.} and J. Chmielecki and Mok, {T. S.K.}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy424.064",

language = "English",

volume = "29",

pages = "viii741",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study

AU - Papadimitrakopoulou, V. A.

AU - Wu, Y. L.

AU - Han, J. Y.

AU - Ahn, M. J.

AU - Ramalingam, S. S.

AU - John, T.

AU - Okamoto, I.

AU - Yang, J. C.H.

AU - Bulusu, K. C.

AU - Laus, G.

AU - Collins, B.

AU - Barrett, J. C.

AU - Chmielecki, J.

AU - Mok, T. S.K.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081530150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081530150&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy424.064

DO - 10.1093/annonc/mdy424.064

M3 - Article

C2 - 32138033

VL - 29

SP - viii741

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -